Skip to main content
. 2014 Sep 16;2014:146170. doi: 10.1155/2014/146170

Table 1.

MicroRNAs associated with PCa diagnosis.

References Sample type miRs deregulated miRs selected as candidate biomarkers
Taylor et al. (2010) [24] 113 PCa tissues
28 normal tissues
Large screening study Taylor et al. 10.1016/j.ccr.2010.05.026

Volinia et al. (2006) [31] 56 PCa tissues
7 normal tissues
39 upregulated
6 downregulated
Volinia et al. 10.1073/pnas.0510565103;

Ambs et al. (2008) [32] 60 microdissected tumor tissues
16 normal tissues
21 upregulated
21 downregulated
miR-32, miR-26a, miR-181a,
miR-93, miR-196a, miR25,
miR-92 and let-7i

Porkka et al. (2007) [38] 5 hormone-naïve PCa tissues
4 HRPC tissues
4 BPH tissues
14 upregulated
37 downregulated
PCa: miR-16, miR-99 and let-7 family
HRPC: miR-205, miR-100 and miR-30

Ozen et al. (2008) [43] 16 PCa tissues and 10 normal tissues 9 upregulated
76 downregulated
Let-7, miR-30, miR-16

Martens-Uzunova et al. (2012) [44] 102 PCa tissues and
normal adjacent tissues
54 deregulated miR-205

Larne et al. (2013) [45] 49 PCa tissues
25 normal tissues
7 deregulated miR-96-5p, miR-183-5p
miR-145-5, miR-221-5p
(combined in miQ score)

Moltzahn et al. (2011) [46] Serum samples from PCa (n = 36) and HD (n = 12) 6 upregulated
4 downregulated
miR-20b, miR-874,
miR-1274a, miR-1207-5p,
miR-93, miR-106a
miR-223, miR-26b,
miR-30c, miR-24

Bryant et al. (2012) [48] Plasma samples from PCa (n = 78) and HD (n = 28)
Urine samples from PCa (n = 118) and HD (n = 17)
12 deregulated miR-107, miR-574-3p

Srivastava et al. (2013) [49] 40 PCa tissues and 40 normal adjacent tissues.
Urine samples from PCa (n = 36)
and HD (n = 12)
2 downregulated miR-205, miR-214

Haj-Ahmad et al. (2014) [50]  Urine samples from PCa (n = 8)
BPH (n = 12) patients and HD (n = 10)
17 deregulated
(only 7 selected for further analysis)
miR-1825 (only in PCa)
miR-484 (in PCa and BPH)  

Schaefer et al. (2010) [54] 76 PCa and adjacent normal tissues 5 upregulated
10 downregulated
miR-96, miR-182, miR-182∗ 
miR-183 and miR-375
miR-16, miR-31, miR-125b,
miR-145, miR-149, miR-181b,
miR-184, miR-205, miR-221, miR-222

PCa: prostate cancer; HRPC: hormone refractory prostate cancer; BPH: benign prostatic hyperplasia; HD: healthy donors, FFPE: formalin-fixed, paraffin-embedded.